1. bookVolumen 62 (2012): Edición 4 (December 2012)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Heterocyclic compounds based on 3-(4-bromophenyl) azo-5-phenyl-2(3H)-furanone: Anti-avian influenza virus (H5N1) activity / Heterociklički derivati 3-(4-bromfenil) azo-5-fenil-2(3H)-furanona: Djelovanje na virus ptičje gripe (H5N1)

Publicado en línea: 15 Jan 2013
Volumen & Edición: Volumen 62 (2012) - Edición 4 (December 2012)
Páginas: 593 - 606
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. A. I. Hashem, A. S. A. Youssef, K. A. Kandeel and W. S. I. Abou-Elmaged, Conversion of some 2(3H)-furanones bearing a pyrazolyl group into other heterocyclic systems with a study of their antiviral activity, Eur. J. Med. Chem. 42 (2007) 934-939; DOI: 10.1016/j.ejmech.2006.12.032.10.1016/j.ejmech.2006.12.03217321008Search in Google Scholar

2. A. I. Hashem, K. A. Kandeel, A. S. A. Youssef and W. S. I. Abou-Elmaged, Behaviour of some 2(3H)-furanones bearing a pyrazolyl group as alkylating agents, J. Chem. Res. 3 (2006) 315-317; DOI: 10.3184/030823406777411115.10.3184/030823406777411115Search in Google Scholar

3. M. S. Christodoulou, S. Liekens, K. M. Kasiotis and S. A. Haroutounian, Novel pyrazole derivatives: Synthesis and evaluation of anti-angiogenic activity, Bioorg. Med. Chem. 18 (2010) 4338-4350; DOI: 10.1016/j.bmc.2010.04.076.10.1016/j.bmc.2010.04.07620493716Search in Google Scholar

4. A. Y. Shaw, H. H Liau, P. J. Lu, C. N. Yang, C. H. Lee, J. Y. Chen, Z. Xu and G. Flynn, 3,5-Diaryl-1H-pyrazole as a molecular scaffold for the synthesis of apoptosis-inducing agents, Bioorg. Med. Chem. 18 (2010) 3270-3278; DOI: 10.1016/j.bmc.2010.03.016.10.1016/j.bmc.2010.03.01620381360Search in Google Scholar

5. J. Choi, Y. Park, H. S. Lee, Y. Yang and S. Yoon, 1,3-Diphenyl-1H-pyrazole derivatives as a new series of potent PPARg partial agonists, Bioorg. Med. Chem. 18 (2010) 8315-8323; DOI: 10.1016/j.bmc.2010.09.068.10.1016/j.bmc.2010.09.06821030263Search in Google Scholar

6. A. Mohammad, K. Harish and S. A. Javed, Pharmacological activities of pyrazole and its derivatives, Hamdard Medicus 52 (2009) 102-118.Search in Google Scholar

7. A. El Maatougui, J. Azuaje, E. Sotelo, O. Caamaño and A. Coelho, Silica-supported aluminum chloride-assisted solution phase synthesis of pyridazinone-based antiplatelet agents, ACS Comb. Sci. 10 (2011) 7-12.10.1021/co100017h21247118Search in Google Scholar

8. A. A. Siddiqui, R. Mishra, M. Shaharyar, A. Husain, M. Rashid and P. Pal, Triazole incorporated pyridazinones as a new class of antihypertensive agents: Design, synthesis and in vivo screening, Bioorg. Med. Chem. Lett. 21 (2011) 1023-1026; DOI: 10.1016/j.bmcl.2010.12.028.10.1016/j.bmcl.2010.12.02821211966Search in Google Scholar

9. I. H. R. Tomi, A. H. J. Al-Qaisi and Z. H. J. Al-Qaisi, Synthesis, characterization and effect of bis-1,3,4-oxadiazole rings containing glycine moiety on the activity of some transferase enzymes, J. King Saud. Univ. Sci. 23 (2011) 23-33; DOI: 10.1016/j.jksus.2010.06.002.10.1016/j.jksus.2010.06.002Search in Google Scholar

10. U. Ghani and N. Ullah, New potent inhibitors of tyrosinase: Novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site, Bioorg. Med. Chem. 18 (2010) 4042-4048; DOI: 10.1016/j.bmc.2010.04.021.10.1016/j.bmc.2010.04.02120452224Search in Google Scholar

11. X. J. Zou, L. H. Lai, G. Y. Jin and Z. X. J. Zhang, Synthesis, fungicidal activity, and 3D-QSAR of pyridazinone-substituted 1,3,4-oxadiazoles and 1,3,4-thiadiazoles, Agr. Food Chem. 50 (2002) 3757-3760; DOI: 10.1021/jf0201677.10.1021/jf020167712059155Search in Google Scholar

12. G. V. S. Kumar, Y. Rajendraprasad, B. P. Mallikarjuna, S. M. Chandrashekar and C. Kistayya, Synthesis of some novel 2-substituted-5-[isopropylthiazole clubbed] 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents, Eur. J. Med. Chem. 45 (2010) 2063-2074; DOI: 10.1016/j.ejmech.2010.01.045.10.1016/j.ejmech.2010.01.04520149496Search in Google Scholar

13. K. Imtiaz, A. Sajid, H. Shahid, H. R. Nasim, T. H. Muhammad, W. Abdul, U. Reaz, U. Zaheer, K. Ajmal, A. M. Sajjad and C. Iqbal, Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives, Eur. J. Med. Chem. 45 (2010) 5200-5207; DOI: 10.1016/j.ejmech.2010.08.034.10.1016/j.ejmech.2010.08.03420828889Search in Google Scholar

14. M. McDowell, S. R. Gonzales, S. C. Kumarapperuma, M. Jeselnik, J. B. Arterburn and K. A. Hanley, A novel nucleoside analog, 1-b-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro, Antivir. Res. 87 (2010) 78-80; DOI: 10.1016/j.antiviral.2010.04.007.10.1016/j.antiviral.2010.04.007289203620416341Search in Google Scholar

15. H. P. Hsieh and J. T. Hsu, Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity, Curr. Pharm. Design 13 (2007) 3531-3542; DOI: 10.1186/1423-0127-17-13.10.1186/1423-0127-17-13283876120178582Search in Google Scholar

16. A. E. Rashad, A. H. Shamroukh, R. E. Abdel-Megeid, A. Mostafa, M. A. Ali and K. Banert, A facile synthesis and anti-avian influenza virus (H5N1) screening of some novel pyrazolopyrimidine nucleoside derivatives, Nucleos. Nucleot. Nucl. 29 (2010) 809-820; DOI: 10.1080/15257770.2010.529480.10.1080/15257770.2010.52948021128168Search in Google Scholar

17. K. Hertogs, M. P. Béthune, V. Miller, T. Ivens, P. Schel, A. Van Cauwenberge, C. Van den Eynde, V. van Gerwen, H. Azijn, M. van Houtte, F. Peeters, S. Staszewski, M. Conant, S. Bloor, S. Kemp, B. Larder and R. Pauwels, A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs, Antimicrob. Agents Chemother. 42 (1998) 269-276.10.1128/AAC.42.2.2691053999527771Search in Google Scholar

18. F. G. Hayden, Plaque inhibition assay for drug susceptibility testing of influenza viruses, Agents Chemother. 17 (1980) 865-870.10.1128/AAC.17.5.8652838897396473Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo